Most prostate cancer patients who choose to undergo active surveillance instead of treatment are not receiving the appropriate disease monitoring, bringing into question whether ... Read more
Men who are diagnosed with prostate cancer at later stages of the disease are ...
The Prostate Cancer Foundation (PCF) has released its comprehensive Prostate Cancer Patient Guide with ...
Xtandi Extends Time to Disease Worsening in Certain Metastatic Prostate Cancer Patients – Without Added Side Effects – Study ShowsXtandi (enzalutamide), an androgen receptor inhibitor, significantly delays disease progression — as assessed through radiological ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according to data recently presented at the European ... Read more